Amicus Therapeutics
Likely to Engage tag.Highly Engaged Employees

Manufacturing · New Jersey, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

47 Hulfish St, Princeton, New Jersey, 08...

Phone Number

(609) 662-2000

Revenue

$634.2 Million

Stock Symbol

FOLD

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Amicus Therapeutics

Amicus Therapeutics is a subsidiary of BioMarin Pharmaceutical Inc., specializing in the development of therapies for rare diseases. The company focuses on delivering innovative medicines for individuals with genetically defined conditions. Guided by the needs of patients living with rare diseases worldwide, Amicus is committed to advancing research and providing support services. Their offerings include clinical trials, expanded access programs, and patient advocacy initiatives.Explore more
Amicus Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: FOLDShow more

Amicus Therapeutics Org Chart

PhoneEmail
DC
United States flag for contact location.

Chief People Officer

PhoneEmail
SH
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JB
United States flag for contact location.

Vice President, Human Resources

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Amicus Therapeutics

Compare insights from companies similar to Amicus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Amicus Therapeutics

$634.2M
501-1,000
Public
$475M
2013
DC
David ClarkChief People Officer
$3.4B
1K - 5K
Public
$1.5B
1992
$1B
501-1,000
Public
$2.5B
1998
Meghan Schwarzenbek, Chief of Staff To the Chief Information Officer at PTC Therapeutics
Meghan SchwarzenbekChief of Staff To the Chief Information Officer
$717M
1K - 5K
Public
$1.6B
2010
EM
Ernie MeyerExecutive Vice President & Chief Human Resources Officer
$276.8M
51-200
Public
$888.4M
1996
EM
Esteban MasudaHead Executive VP, Research
$101.3M
201-500
Private
$1.5B
2002
SK
Steve KillmeyerChief Financial Officer
$98.3M
501-1,000
Public
$106M
2008
Brian Goff, Chief Executive Officer & Member Board of Directors at Agios
Brian GoffCEO & Member Board of Directors
Illustration of an envelope

Amicus Therapeutics Tech Stack

A closer look at the technologies used by Amicus Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Amicus Therapeutics

What is Amicus Therapeutics's stock symbol?
Amicus Therapeutics's stock symbol is FOLD
What is Amicus Therapeutics's official website?
Amicus Therapeutics's official website is www.amicusrx.com
What is Amicus Therapeutics's Revenue?
Amicus Therapeutics's revenue is $634.2 Million
What is Amicus Therapeutics's SIC code?
Amicus Therapeutics's SIC: 28,283
What is Amicus Therapeutics's NAICS code?
Amicus Therapeutics's NAICS: 32,325
How many employees does Amicus Therapeutics have?
Amicus Therapeutics has 501-1,000 employees
What industry does Amicus Therapeutics belong to?
Amicus Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Amicus Therapeutics competition?
Amicus Therapeutics top competitors include: PTC Therapeutics, Ultragenyx, Agios, Rigel
What companies has Amicus Therapeutics acquired?
Amicus Therapeutics has acquired the companies: Amicus Therapeutics, ZyStor Therapeutics, Alesta, Synapse Technologies
What technology does Amicus Therapeutics use?
Some of the popular technologies that Amicus Therapeutics uses are: DocuSign, WordPress.org, iCIMS, PHP
Who is the CFO of Amicus Therapeutics?
Amicus Therapeutics's CFO is Simon Harford
What does Amicus Therapeutics do?

Amicus Therapeutics is a subsidiary of BioMarin Pharmaceutical Inc., specializing in the development of therapies for rare diseases. The company focuses on delivering innovative medicines for individuals with genetically defined conditions. Guided by the needs of patients living with rare diseases worldwide, Amicus is committed to advancing researc... h and providing support services. Their offerings include clinical trials, expanded access programs, and patient advocacy initiatives.Read More

What are Amicus Therapeutics social media links?
Amicus Therapeutics Linkedin page Amicus Therapeutics Twitter page Amicus Therapeutics Facebook page
Is Amicus Therapeutics a public company?
Yes, Amicus Therapeutics is a public company and is traded under the symbol FOLD
See more information about Amicus Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.